Efficacy and Safety of Transradial and Femoral Artery Coronary Intervention in Elderly Patients with Acute Coronary Syndrome

doi:10.3877/cma.j.issn.2095-6568.2017.03.007

Abstract

Abstract:

Objective

To investigate the clinical value of transradial and femoral artery coronary intervention in the treatment of elderly patients with acute coronary syndrome.

Methods

Fifty elderly patients with acute coronary syndrome who were treated in our hospital from May 2016 to August 2017 were randomly divided into two groups of 25 patients.The control group was treated with PCI via the femoral artery.The patients in the observation group underwent radial artery PCI.The operative conditions, operative success rates, major cardiovascular events and complications of the puncture site were compared between the two groups.

Results

There was no significant difference in contrast agent dosage, X-ray exposure time, operation time and the total incidence of major cardiovascular events between the two groups (P>0.05). Compared with the control group, the puncture time, postoperative bed rest Time, postoperative discharge time were shorter, the incidence of complications at the puncture site was lower, the difference was statistically significant (P<0.05).

Conclusions

The success rate of transradial and transthoracic PCI is similar, but the transradial artery can effectively reduce the major cardiovascular events and the complications of the puncture site.The postoperative bed rest time is short and has good safety.

Key words: Elderly acute coronary syndrome, Transradial, Femoral artery coronary, Safety

Hui Yan, Zhongyu Zhao, Jiangtao Wang, Xueyi Wang, Yue Sun. Efficacy and Safety of Transradial and Femoral Artery Coronary Intervention in Elderly Patients with Acute Coronary Syndrome[J]. Chinese Journal of Heart and Heart Rhythm(Electronic Edition), 2017, 05(03): 153-155.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhxzyxldzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-6568.2017.03.007

https://zhxzyxldzzz.cma-cmc.com.cn/EN/Y2017/V05/I03/153

Figures/Tables 2

References 8

[1]	杨磊，王春玲，刘伟学，等.70岁以上高龄冠心病患者经桡动脉和股动脉途径行经皮冠状动脉介入治疗(PCI)后的疗效观察[J]．中国医药导刊，2017，19(5)：442-443，445.
[2]	李洁荣，吕云，高彦．经桡动脉和股动脉途径行经皮冠状动脉介入治疗高龄冠心病的疗效比较[J]．中西医结合心脑血管病杂志，2016，14(8)：891-893.
[3]	朱丹，郭彩艳，缪思斯，等.80岁以上高龄冠心病患者经桡动脉行冠状动脉介入诊疗的可行性分析[J]．中国循环杂志，2016，31(10)：966-969.
[4]	刘杲，缪金龙，许岭平．经桡动脉和股动脉途径行经皮冠状动脉介入治疗高龄冠心病患者疗效比较[J]．安徽医学，2016，37(6)：696-698.
[5]	卢思稼，韦伟，马建林．经股动脉途径和桡动脉途径穿刺介入术治疗高龄冠心病的临床比较[J]．中国老年学杂志，2015，35(9)：2523-2524，2525.
[6]	张慧，蒋文彬，崔美平，等．经桡动脉和股动脉途径PCI治疗高龄冠心病患者的临床效果分析[J]．现代生物医学进展，2015，15(10)：1916-1918，1922.
[7]	王岳松，邵旭武，王学忠，等．老年急性心肌梗死患者经桡动脉直接冠状动脉介入治疗特点和疗效[J]．中华老年心脑血管病杂志，2015，17(11)：1204-1205.
[8]	秦毅，李原，孙运强．经皮桡动脉入路在急性心肌梗死直接冠状动脉介入治疗中的疗效观察及对炎性因子的影响[J]．中国医师进修杂志，2017，40(10)：869-872.

组别	X线曝光时间(min)	穿刺时间(min)	造影剂用量(mL)	手术时间(min)	术后卧床时间(d)	术后住院时间(d)
对照组(n＝25)	36.85±8.42	6.75±1.93	183.55±50.17	61.51±18.26	20.38±5.51	9.39±2.07
观察组(n＝25)	35.71±8.41	4.20±1.05	180.27±49.26	61.53±18.17	5.36±1.09	5.63±1.25
t值	0.479	5.803	0.233	0.004	13.371	7.775
P值	>0.05	<0.05	>0.05	>0.05	<0.05	<0.05

组别	X线曝光时间(min)	穿刺时间(min)	造影剂用量(mL)	手术时间(min)	术后卧床时间(d)	术后住院时间(d)
对照组(n＝25)	36.85±8.42	6.75±1.93	183.55±50.17	61.51±18.26	20.38±5.51	9.39±2.07
观察组(n＝25)	35.71±8.41	4.20±1.05	180.27±49.26	61.53±18.17	5.36±1.09	5.63±1.25
t值	0.479	5.803	0.233	0.004	13.371	7.775
P值	>0.05	<0.05	>0.05	>0.05	<0.05	<0.05

组别	出血	血肿	血管迷走反射	假性动脉瘤	总发生率
对照组(n＝25)	2(8.00)	4(16.00)	1(4.00)	1(4.00)	8(32.00)
观察组(n＝25)	0(0.00)	1(4.00)	0(0.00)	0(0.00)	1(4.00)^a

组别	出血	血肿	血管迷走反射	假性动脉瘤	总发生率
对照组(n＝25)	2(8.00)	4(16.00)	1(4.00)	1(4.00)	8(32.00)
观察组(n＝25)	0(0.00)	1(4.00)	0(0.00)	0(0.00)	1(4.00)^a

[1]	Jinglong He, Hongxi Shang, Min Hao, Wei Xie, Minghong Gao, Wei Sun, Anqing Liu. Clinical effect of multiple joints replacements in patients with severe rheumatoid arthritis [J]. Chinese Journal of Joint Surgery(Electronic Edition), 2023, 17(06): 860-864.
[2]	Meicen Zhou, Hua Wang, Dezhi Mu. Vaccination timeliness in preterm infants: a review of literature [J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2023, 19(03): 261-266.
[3]	Haiqin Tang, Xiuzhi Guo, Xiaosu Zhu, Shidi Zhao. Clinical safety study of "tunnel method" laparoscopic anatomic left hemihepatectomy [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(06): 674-677.
[4]	Jie Zhang, Yuan Lyu, Liang Sun, Hui Su, Hui Xie, Qiang Yuan, Xin Wang, Junfeng Du, Peng Jin, Gang Chen. Clinical analysis of combined laparoscope-gastroscopy for the treatment of difficult gastric stromal tumors [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2023, 17(03): 284-286.
[5]	Jun Liu, Ji Zhu, Jun Yin. Anesthesia effect and safety of dexmedetomidine in inguinal hernia surgery [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2023, 17(05): 570-573.
[6]	Hongmin Wang, Yunbo Xie, Yanhu Wang, Fusheng Wang. The advance of clinical research in mesenchymal stem cell treatment for COVID-19 [J]. Chinese Journal of Cell and Stem Cell(Electronic Edition), 2023, 13(04): 247-256.
[7]	Fengjie Wang, Liguang Wang, Shan Liao, Ying Liu, Rongdang Fu, Huanwei Chen. Safety and efficacy of laparoscopic right hemihepatectomy for hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(05): 517-522.
[8]	Jie Huang. Concerns on laparoscopic liver surgery [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 267-271.
[9]	Qingquan Fan, Xiaoling Song, Mingzhe Weng, Jun Gu. Safety and efficacy of ERCP after digestive tract reconstruction [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2023, 12(03): 331-335.
[10]	Heya Na, Dan Zhu. Effect of red-light therapy in myopia control in children [J]. Chinese Journal of Ophthalmologic Medicine(Electronic Edition), 2023, 13(04): 252-256.
[11]	Wenlong Liang, Jie Cao, Qing Huang, Yong Lin, Hongli Huang, Ping Yang, Guanwei Li, He Hu. Efficacy and safety analysis of sintilimab combined with regofenib in the treatment of advanced colorectal cancer [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(06): 409-413.
[12]	Tingting Chen, Xueliang Jiang, Jiali Yu, Jianlin Ke. Safety of stem cells in the treatment of inflammatory bowel disease [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2023, 13(04): 193-198.
[13]	Wenxi Cao, Xiao Chen, Laifa Zhu, Yongping Zhou. Efficacy and safety of nituzumab combined with albumin bound paclitaxel in treatment of pancreatic cancer [J]. Chinese Journal of Clinicians(Electronic Edition), 2023, 17(04): 409-413.
[14]	Jun Liang, Chenyu Chu, Fengyan Sun, Yilang Yuan, Xi Zhou, Weidong Wang. Feasibility and safety of reverse puncture with tunnel needle in totally implantable venous access port [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2023, 11(04): 310-313.
[15]	Xueqing Huang, Nan Wei, Tianpeng Jiang, Tianzhi An, Min Xu, Shi Zhou. Clinical study of TACE for hepatocellular carcinoma by ultrasound-guided transdistal radial artery approach [J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2023, 11(03): 251-256.

Please choose a citation manager

Content to export